Study of Oncolytic Virus in Combination With HX-008 and Radiotherapy in Melanoma Patients With Liver Metastasis

NCT05068453 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Melanoma Stage IV

Interventions

DRUG: Recombinant Oncolytic HSV-2 Therapeutic Injecta (Vero Cell) for Human Use (rHSV2hGM-CSF)
DRUG: Recombinant humanized anti-PD-1 monoclonal antibody for injection
RADIATION: RT

Sponsor

Peking University Cancer Hospital & Institute